CVRdatabase
Menu

Pharmaceutical Econsulting A/S

Public limited companyCVR 30815378GlostrupActive

Pharmaceutical Econsulting A/S is a public limited company, based in Glostrup, active in other professional, scientific and technical activities n.e.c., founded in 2007. The company made a loss in both 2024 and 2025, most recently DKK 1.1m. With 9 employees, the company is about 5 times larger than the industry median. Equity fell to DKK 5.2m in 2025.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 6.1m+10.4% vs. 2024
Net profit−DKK 1.1m−65.7% vs. 2024
EquityDKK 5.2m−17.2% vs. 2024
Employees9latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit rose 10% (2024 → 2025), to DKK 6.1m.
  • The loss grew: from DKK 644k to DKK 1.1m (2024 → 2025).
  • Equity fell 17% (2024 → 2025), to DKK 5.2m.

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 2mDKK 0DKK 2mDKK 4mDKK 6mDKK 8m202020212022202320242025
EquityNet profit
Financial figures for Pharmaceutical Econsulting A/S
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit6,9478,2766,7795,5795,5386,114+10.4%
Operating profit (EBIT)2,9783,050770−395−941−1,268−34.7%
Profit before tax3,0153,1081,007−303−892−1,245−39.6%
Net profit2,3452,420780−384−644−1,067−65.7%
Total assets17,13219,6588,0927,9918,80610,595+20.3%
Equity4,0486,4677,2476,8636,2205,153−17.2%
Liabilities13,08413,1908451,1272,5795,443+111%
Cash and cash equivalents1,4062,82560363515935+81.4%
Average number of employees458880−100%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 2mDKK 4mDKK 6mDKK 8m202020212022202320242025
Gross profitMedian, the industry (310 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Loss for 3 years in a row

    Net result has been negative in 2023–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Pharmaceutical Econsulting A/S
Financial yearPeriodPublishedFigures forDocuments
202501/10/2024 – 30/09/202517/04/2026The companyPDF not statedXBRL
202401/10/2023 – 30/09/202411/04/2025The companyPDFXBRL
202301/10/2022 – 30/09/202325/04/2024The companyPDFXBRL
202201/10/2021 – 30/09/202206/04/2023The companyPDFXBRL
202101/10/2020 – 30/09/202116/03/2022The companyPDFXBRL
202001/10/2019 – 30/09/202006/03/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
024681009/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

310 companies in the database

Comparison with the other companies in other professional, scientific and technical activities n.e.c. based on the latest financial year.

Gross profitDKK 6.1mNo. 77 of 309
Better than 75% of the companies in the industry
EquityDKK 5.2mNo. 57 of 310
Better than 82% of the companies in the industry
Number of employees9No. 279 of 310
Better than 10% of the companies in the industry

Industry median: gross profit DKK 1.9m, net profit DKK 142k, equity DKK 1.1m, 2 employees.

DKK 100kDKK 708kDKK 5mDKK 35.5mDKK 130.8mHere
Distribution of gross profit for 278 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 10,436of 69,742
Better than 85%
No. 13,885of 69,964
Better than 80%
Same industry and fewer than 20 employees281 companies in the comparison
No. 50of 281
Better than 83%
No. 37of 281
Better than 87%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 8,538of 24,791
Better than 66%
No. 9,581of 24,909
Better than 62%
All companies of type A/S18,025 companies in the comparison
No. 11,135of 17,786
Better than 37%
No. 11,374of 18,024
Better than 37%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Other professional, scientific and technical activities n.e.c.
Gross profit
  1. Pharmaceutical Econsulting A/SDKK 6.1m
  2. Clearwater Denmark K/SDKK 251.1m
  3. Bureau Veritas Denmark A/SDKK 149.1m
Net profit
  1. Pharmaceutical Econsulting A/S−DKK 1.1m
  2. Clearwater Denmark K/SDKK 134.2m
  3. Bureau Veritas Denmark A/SDKK 17.3m
Equity
  1. Pharmaceutical Econsulting A/SDKK 5.2m
  2. Clearwater Denmark K/SDKK 76.4m
  3. Bureau Veritas Denmark A/SDKK 18.7m
Employees
  1. Pharmaceutical Econsulting A/S9
  2. Clearwater Denmark K/S56
  3. Bureau Veritas Denmark A/S161

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Rugaard Holding ApS100%
Pharmaceutical Econsulting A/S

Management

4 active registrations

Executive management

Executive management at Pharmaceutical Econsulting A/S
NameRoleAppointed
Steen Otto RugaardCEO14/06/2016

Board of directors

Board of directors at Pharmaceutical Econsulting A/S
NameRoleAppointed
Hanne Laurberg OlesenBoard member14/06/2016
Steen Otto RugaardBoard member14/06/2016
Pernille Laurberg RugaardChair of the board14/06/2016
Auditor
Optimal Revision Godkendt Revisionsvirksomhed
Founders
Rugaard Holding ApS
Former management (6)
Former management at Pharmaceutical Econsulting A/S
NameRoleAppointedResigned
Hanne Laurberg OlesenBoard member03/09/200730/12/2015
Steen Otto RugaardBoard member03/09/200706/04/2016
Steen Otto RugaardDirector03/09/200706/04/2016
Jens Christian Pii OlesenDeputy chair01/10/200731/12/2015
Pernille Laurberg RugaardChair of the board01/10/200706/04/2016
Hanne Laurberg OlesenDeputy chair31/12/201506/04/2016

Signing rule: Selskabet tegnes af en direktør i forening med et medlem af bestyrelsen eller af den samlede bestyrelse.

Address and production units

1 active production units

Naverland 2
2600 Glostrup

Albertslund Municipality · Postcode 2600

Other companies at the address (2)

  • Kks ApSCombined facilities support activities
  • Ram Service ApSAccounting, bookkeeping and auditing; tax consultancy
Production units
Production unitAddressEmployeesP number
PHARMACEUTICAL ECONSULTING A/SNaverland 2, 10, 2600 Glostrup91013575963

Purpose

Selskabets formål er at drive virksomhed med salg af konsulentydelser og rådgivning indenfor farmaceutisk industri samt anden efter ledelsens skøn dermed beslægtet virksomhed.

The purpose is quoted from the register in Danish.

Changes year by year

29 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20251 changeaccounts 1
  • Annual report for 2024 published
20241 changeaccounts 1
  • Annual report for 2023 published
20231 changeaccounts 1
  • Annual report for 2022 published
20221 changeaccounts 1
  • Annual report for 2021 published
20211 changeaccounts 1
  • Annual report for 2020 published
20191 changeaddress 1
  • Moved to Naverland 2, 10, 2600 Glostrup
201610 changesstatus 2 · management 8
  • Status changed to active
  • Hanne Laurberg Olesen appointed board member
  • Pernille Laurberg Rugaard appointed chair of the board
  • Steen Otto Rugaard appointed board member
  • Steen Otto Rugaard appointed ceo
  • Status changed to under compulsory dissolution
  • Hanne Laurberg Olesen stepped down as deputy chair
  • Pernille Laurberg Rugaard stepped down as chair of the board
  • Steen Otto Rugaard stepped down as director
  • Steen Otto Rugaard stepped down as board member
20153 changesmanagement 3
  • Hanne Laurberg Olesen appointed deputy chair
  • Jens Christian Pii Olesen stepped down as deputy chair
  • Hanne Laurberg Olesen stepped down as board member
20081 changeindustry 1
  • Industry changed to Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n. (749090)
20078 changesaddress 1 · management 5 · founded 1 · ownership 1
  • Moved to Naverland 2, 10, 2600 Glostrup
  • Pernille Laurberg Rugaard appointed chair of the board
  • Jens Christian Pii Olesen appointed deputy chair
  • Registered as PHARMACEUTICAL ECONSULTING A/S
  • Hanne Laurberg Olesen appointed board member
  • Steen Otto Rugaard appointed director
  • Steen Otto Rugaard appointed board member
  • RUGAARD HOLDING ApS registered as owner (100%)

Related companies

Same industry in Albertslund

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVRReport a correction